| A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients (NCT06788197) | Henan Cancer Hospital | 2025-03-01 |
| Post-extubation Nasal Humidified High-flow Oxygen Versus Non-invasive Positive Pressure Ventilation (NCT06918288) | Benha University | 2025-03-01 |
| Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS) (NCT05646199) | University of Hull | 2025-03-01 |
| Efficacy of Tooth Bleaching With 35% and 6% Hydrogen Peroxide in Primary Dentition (NCT05789004) | University of Nove de Julho | 2025-03-01 |
| Efficacy of OsteoBor in Postmenopausal Osteoporosis (NCT06809816) | Tabriz University of Medical Sciences | 2025-03-01 |
| A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR101 in the Treatment of Subjects With Interstitial Lung Disease (NCT06825169) | Nuwacell Biotechnologies Co., Ltd. | 2025-03-01 |
| The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease (NCT06819514) | Guangzhou Jiayin Biotech Ltd | 2025-03-01 |
| A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease (NCT06816810) | Ottawa Hospital Research Institute | 2025-03-01 |
| SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism (NCT07482020) | Huashan Hospital | 2025-03-01 |
| Study on the Regulatory Effects of Personalized Innovative Youtiao Intervention on Nutritional Health (NCT06422429) | Yu Zhang | 2025-03-01 |
| Effects of Esketamine Versus Magnesium Sulfate on Emotional State and Postoperative Pain in Patients Undergoing Nasal Endoscopic Surgery (NCT06920576) | The Second People's Hospital of Huai'an | 2025-03-01 |
| Cetuximab + Tislelizumab + Chemotherapy in the Treatment of Unresectable LA HNSCC (NCT06978829) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2025-03-01 |
| Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke (NCT06297863) | University of Milano Bicocca | 2025-03-01 |
| A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL (NCT06557161) | The First Affiliated Hospital of Zhengzhou University | 2025-03-01 |
| Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC (NCT06861777) | YIN LI | 2025-03-01 |
| Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis (NCT06971380) | Polina Stepensky | 2025-03-01 |
| A Study of Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People With Metastatic Colorectal Cancer (NCT06967155) | Blokhin's Russian Cancer Research Center | 2025-03-01 |
| Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer (NCT06871527) | Sixth Affiliated Hospital, Sun Yat-sen University | 2025-03-01 |
| Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis (NCT06770842) | The University of Hong Kong | 2025-03-01 |
| Using Lidocaine or Dexmedetomidine to Help Control Blood Pressure Spikes From a Tourniquet During Knee Surgery (NCT06936410) | Cairo University | 2025-03-01 |
| Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies (NCT06854276) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2025-03-01 |
| Herbal Ointment in Treating Atopic Dermatitis Topically (NCT06850311) | En Chu Kong Hospital | 2025-03-01 |
| Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC (NCT05195294) | Lion TCR Pte. Ltd. | 2025-03-01 |
| A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL (NCT06564493) | The First Affiliated Hospital of Zhengzhou University | 2025-03-01 |
| The Effect Of Using Sticky Bone With Coronally Advanced Flap In Management Of Type 1 Gingival Recession (NCT06871475) | Minia University | 2025-03-01 |
| A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer (NCT06978400) | Blokhin's Russian Cancer Research Center | 2025-03-01 |
| Perioperative Immunotherapy for Resectable Limited-Stage SCLC (NCT07109401) | Fudan University | 2025-03-01 |
| Effectiveness of a Personalized In-home Telerehabilitation Program on Self-Care in Patients with Long COVID (NCT06822179) | CEU San Pablo University | 2025-03-01 |
| PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM (NCT06788171) | Fujian Cancer Hospital | 2025-03-01 |
| Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer (NCT06310369) | European Organisation for Research and Treatment of Cancer - EORTC | 2025-03-01 |
| Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study (NCT06843681) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-03-01 |
| Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases (NCT06821659) | Peking University Third Hospital | 2025-03-01 |
| A Study of QL1706 Combined with Nine HPV Vaccine As First-line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer (NCT06882447) | Northern Jiangsu People's Hospital | 2025-03-01 |
| Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial (NCT06798948) | Li Lab,MD | 2025-03-01 |
| A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL (NCT06564545) | The First Affiliated Hospital of Zhengzhou University | 2025-03-01 |
| Tyrosine Kinase 2 (TYK2) for GA and CS (NCT06725264) | Yale University | 2025-03-01 |
| Tislelizumab in Combination with Chemotherapy ± Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer. (NCT06851819) | Hebei Medical University Fourth Hospital | 2025-03-01 |
| IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure (NCT06866600) | HELP Therapeutics Co., Ltd. | 2025-03-01 |
| Β-OHB Supplementation and Brain Health in Older Adults (NCT06588946) | McMaster University | 2025-03-01 |
| Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study (NCT06225232) | McMaster University | 2025-03-01 |
| Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated Ameloblastoma (NCT06819605) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2025-03-01 |
| Stem Cell Therapy for Intracerebral Hemorrhage (NCT06862388) | Tang Zhouping | 2025-03-01 |
| Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNC (NCT06815679) | Università degli Studi di Ferrara | 2025-03-01 |
| KPD Consolidation After ASCT in NDMM Patients (NCT06879379) | Peking University People's Hospital | 2025-03-01 |
| Silver Nitrate vs. Triamcinolone for Treatment of Hypergranulation Tissue (NCT06681194) | Francesco Egro | 2025-03-01 |
| Dexmedetomidine Versus Fentanyl as Adjuvants to Erector Spinae Plane Block for Postoperative Analgesia Following Simple Nephrectomy: A Randomized Clinical Trial (NCT06799442) | Assiut University | 2025-03-01 |
| The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1 (NCT06030843) | Chulalongkorn University | 2025-03-01 |
| Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma (NCT06848920) | Zhejiang University | 2025-03-01 |
| The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer. (NCT06851299) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-03-01 |
| Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward) (NCT06475781) | Foresee Pharmaceuticals Co., Ltd. | 2025-03-01 |
| Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC (NCT06849167) | Peking University Cancer Hospital & Institute | 2025-03-01 |
| Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT (NCT06861348) | First Affiliated Hospital of Zhejiang University | 2025-03-01 |
| Firmonertinib Combined With Chemotherapy as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutanted NSCLC (NCT06890182) | Tianjin Medical University Cancer Institute and Hospital | 2025-03-01 |
| Cleaning the Biopsy Needle in TRUS Bx (NCT06836271) | Hitit University | 2025-03-01 |
| Double-blind Pilot Study on the Effect of Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperative Patients (NCT06968000) | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 2025-03-01 |
| Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease (NCT06158620) | University of Texas Southwestern Medical Center | 2025-03-01 |
| Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis (NCT05517980) | Kira Pharmacenticals (US), LLC. | 2025-03-01 |
| Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer (NCT06854250) | Sun Yat-sen University | 2025-03-01 |
| Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients With Advanced HER2-Negative Breast Cancer With Brain Metastasis (NCT06839560) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-03-01 |
| Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity (NCT06299891) | Seattle Children's Hospital | 2025-03-01 |
| Efficacy of Dexmedetomidine As an Adjuvant to Bupivacaine in Pericapsular Nerve Group Block in Hip Replacement Surgeries (NCT06736392) | Assiut University | 2025-03-01 |
| N-of-1 in ATS and MEPPC (NCT06205550) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2025-03-01 |
| QL1706 in Combination With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced, Resectable Esophageal Squamous Cell Carcinoma (NCT06852456) | Qilu Pharmaceutical Co., Ltd. | 2025-03-01 |
| Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma (NCT06741020) | Zhejiang Cancer Hospital | 2025-03-01 |
| Intravitreal Topotecan for Prevention or Treatment of Proliferative Vitreoretinopathy in Retinal Detachment (NCT06818721) | Unity Health Toronto | 2025-03-01 |
| AMG510 (sotorasib) Plus Lenvatinib As Second-line Treatment in Patients with KRASG12C Mutant, Metastatic NSCLC (NCT06068153) | ETOP IBCSG Partners Foundation | 2025-03-01 |
| A Study of NTRX-07 in Participants With Alzheimer's Disease (NCT07058688) | NeuroTherapia, Inc. | 2025-03-01 |
| Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans (NCT06940895) | Narrows Institute for Biomedical Research | 2025-03-01 |
| NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia (NCT06706414) | Martin Blomberg Jensen | 2025-03-01 |
| To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients (NCT06589518) | Jongman Kim | 2025-03-01 |
| Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial) (NCT06859684) | West China Hospital | 2025-03-01 |
| Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus (NCT05504187) | Kira Pharmacenticals (US), LLC. | 2025-03-01 |
| Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer (NCT06521866) | Fudan University | 2025-03-01 |
| Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes (NCT06847178) | Shanghai Changzheng Hospital | 2025-03-01 |
| Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma (NCT07179900) | Hebei Medical University Fourth Hospital | 2025-03-01 |
| Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome (NCT06967038) | Bangdong Gong | 2025-02-28 |
| Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule (NCT06812988) | Sanofi | 2025-02-28 |
| Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer (NCT06576115) | Barbara Ann Karmanos Cancer Institute | 2025-02-28 |
| Study of the Oral Treatment MTR-601 in Cervical Dystonia (NCT06830642) | Motric Bio | 2025-02-28 |
| Evaluation of the Benefit and Safety of Localized Tissue Hydration in the Management of Chronic Low Back Pain (NCT06471998) | GCS Ramsay Santé pour l'Enseignement et la Recherche | 2025-02-28 |
| A Phase 2 in Adult Subjects With Hereditary Angioedema (NCT06846398) | Shanghai Argo Biopharmaceutical Co., Ltd. | 2025-02-28 |
| Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study (NCT06820762) | The Second Affiliated Hospital of Dalian Medical University | 2025-02-28 |
| Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ (NCT06808971) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-02-28 |
| Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer (NCT06856187) | Fudan University | 2025-02-28 |
| A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension (NCT06785454) | Mineralys Therapeutics Inc. | 2025-02-28 |
| Ensartinib in the Treatment of ALK Positive or MET Exon 14 Skipping Anvanced Solid Tumors Excluded Lung Cancer (NCT06762327) | Nanjing First Hospital, Nanjing Medical University | 2025-02-28 |
| Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis (NCT06517875) | GlaxoSmithKline | 2025-02-28 |
| Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites (NCT06812390) | Anahita Rabiee MD MHS | 2025-02-28 |
| Celecoxib for ENT Pain Management (NCT06505187) | University of Wisconsin, Madison | 2025-02-28 |
| Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy (NCT06862596) | Masahisa Katsuno | 2025-02-28 |
| Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer (NCT06942416) | Shandong Cancer Hospital and Institute | 2025-02-28 |
| Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel (NCT06523621) | Wake Forest University Health Sciences | 2025-02-28 |
| Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction (NCT06831149) | Matthew Spector | 2025-02-28 |
| Promoting Active Therapy: Path to Wellness (NCT06858189) | Kansas State University | 2025-02-28 |
| A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma (NCT06717126) | iOnctura | 2025-02-27 |
| Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions (NCT06561087) | M.D. Anderson Cancer Center | 2025-02-27 |
| Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCL (NCT06570447) | Tianjin Medical University Cancer Institute and Hospital | 2025-02-27 |
| A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002) (NCT06780137) | Merck Sharp & Dohme LLC | 2025-02-27 |
| Sirolimus for Leigh Syndrome (NCT06843811) | Matthew Demczko | 2025-02-27 |
| Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy (NCT06780670) | Novartis Pharmaceuticals | 2025-02-27 |